HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kathryn M Lemberg Selected Research

Kathryn M Lemberg Research Topics

Disease

6Neoplasms (Cancer)
01/2021 - 05/2011
2Neurofibrosarcoma (MPNST)
01/2020 - 01/2020
2Sarcoma (Soft Tissue Sarcoma)
01/2020 - 01/2020
1Neurofibromatosis 1 (Neurofibromatosis Type I)
01/2020
1Lymphoma (Lymphomas)
11/2019
1Necrosis
05/2012

Drug/Important Bio-Agent (IBA)

4ProdrugsIBA
01/2021 - 01/2018
4Glutamine (L-Glutamine)FDA Link
01/2021 - 01/2018
2purineIBA
01/2021 - 01/2020
1phosphoribosyl-N-formylglycineamideIBA
01/2021
1JHU395IBA
01/2020
1Neurofibromin 1 (Neurofibromin)IBA
01/2020
1NitrogenIBA
01/2020
1CarbonIBA
01/2020
1IsotopesIBA
01/2020
1Lysine (L-Lysine)FDA Link
11/2019
1DiazooxonorleucineIBA
11/2019
1Carboxylesterase (Hydrolase S)IBA
11/2019
1Biomarkers (Surrogate Marker)IBA
01/2018
1IronIBA
05/2012
1ferrostatin-1IBA
05/2012
1Glutamic Acid (Glutamate)FDA Link
05/2012
1erastinIBA
05/2011
1QuinazolinonesIBA
05/2011
1LigandsIBA
05/2011

Therapy/Procedure

1Therapeutics
01/2021
1Drug Therapy (Chemotherapy)
01/2020